70 results match your criteria: "From the Memorial Sloan Kettering Cancer Center.[Affiliation]"

Obesity and inflammation: new insights into breast cancer development and progression.

Am Soc Clin Oncol Educ Book

November 2015

From the Memorial Sloan-Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY.

The importance of inflammation in promoting carcinogenesis and tumor progression is well recognized. Chronic inflammation caused by a variety of infectious agents can lead to the development of several common malignancies. Similarly, inflammatory bowel disease is a well-known risk factor for colorectal cancer.

View Article and Find Full Text PDF

Surveillance and monitoring in breast cancer survivors: maximizing benefit and minimizing harm.

Am Soc Clin Oncol Educ Book

November 2015

From the Memorial Sloan-Kettering Cancer Center, New York, NY; University of Michigan Medical Center, Ann Arbor, MI; Schools of Medicine and Public Health, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA.

Although the incidence of breast cancer has increased, breast cancer mortality has decreased, likely as a result of both breast cancer screening and improved treatment. There are well over two million breast cancer survivors in the United States for whom appropriate surveillance continues to be a subject of controversy. The guidelines from the American Society of Clinical Oncology (ASCO) and the American College of Physicians are clear: only performance of yearly screening mammography is supported by evidence.

View Article and Find Full Text PDF

The magnitude of effect of cosmetic breast augmentation on patient satisfaction and health-related quality of life.

Plast Reconstr Surg

July 2012

New York, N.Y.; Plymouth, United Kingdom; and Hamilton, Ontario, and Vancouver, British Columbia, Canada From the Memorial Sloan-Kettering Cancer Center, Peninsula College of Medicine and Dentistry, McMaster University, and University of British Columbia.

Background: The objective of this study was to gain a better understanding of the magnitude of clinical change in health-related quality of life and patient satisfaction brought about by cosmetic breast augmentation.

Methods: A prospective, longitudinal study was performed. Women undergoing cosmetic breast augmentation were asked to complete the BREAST-Q Augmentation module both before and after augmentation.

View Article and Find Full Text PDF

Melanoma of the lentigo maligna subtype presents diagnostic and treatment challenges because of ill-defined clinical margins in cosmetically and functionally sensitive areas of the head and neck with extensive sun damage. This review highlights the natural history, varied clinical presentations, and pitfalls in histologic diagnosis. The focus is on the surgical management, comparing excision and pathologic tissue processing techniques of wide excision, Mohs micrographic surgery, and staged excision.

View Article and Find Full Text PDF

Grief is essentially unavoidable and is a normal reaction to loss. Grief may be experienced by patients and their loved ones as well as by physicians and members of the health care team in response to the consequences of illness or death. Grief is typified by certain indicators that may significantly effect one's emotional and physical well-being.

View Article and Find Full Text PDF

The number of cancer survivors in the United States now approaches 12 million individuals, with an estimated 7.2% of the general population aged 18 years or older reporting a previous cancer diagnosis. These figures highlight a number of questions about the care of survivors-how patients at risk for a known set of health problems should be followed, by whom, and for how long.

View Article and Find Full Text PDF

The oncologist as the patient with cancer or relative.

Am Soc Clin Oncol Educ Book

April 2016

From the Memorial Sloan-Kettering Cancer Center, New York, NY; M. D. Anderson Cancer Center, Houston, TX; University of Indiana, Indianapolis, IN.

To an extent, physicians are familiar with the consequences of illness through their interactions with patients. However, when cancer becomes personal, the physician has an opportunity to gain greater insight into the intricacies of medical care, including its humanistic elements. Physicians who encounter cancer in themselves or in a relative may deepen their understanding of the patient experience.

View Article and Find Full Text PDF

Antiemetic Use in Oncology: Updated Guideline Recommendations from ASCO.

Am Soc Clin Oncol Educ Book

April 2016

From the Memorial-Sloan Kettering Cancer Center, New York, NY; American Society of Clinical Oncology, Alexandria, VA; Lahey Clinic Medical Center; Burlington, MA; Duke University, Durham, NC.

In 2011, ASCO updated its guideline for the use of antiemetics in oncology, informed by a systematic review of the medical literature. This is an abbreviated version of that guideline, which is available in full at www.asco.

View Article and Find Full Text PDF

Uterine sarcomas: histology and its implications on therapy.

Am Soc Clin Oncol Educ Book

April 2016

From the Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

Uterine sarcomas are rare cancers, they comprise only 5% of all uterine malignancies. There are about 2,000 cases of uterine sarcoma diagnosed annually in the United States. Uterine sarcomas may be categorized as either favorable-risk, low-grade malignancies with a relatively good prognosis or as poor-risk, high-grade cancers that carry a high risk for tumor recurrence and disease progression.

View Article and Find Full Text PDF

Interventional radiologists (IRs) have an expanding role in the treatment of liver metastases from colorectal cancer. Increasing data on the ability to treat liver metastases with locoregional therapies has solidified this position. Ablative approaches, such as radiofrequency ablation and microwave ablation, have shown durable eradication of tumors.

View Article and Find Full Text PDF

Mammography is the only breast imaging examination that has been shown to reduce breast cancer mortality. Population-based sensitivity is 75% to 80%, but sensitivity in high-risk women with dense breasts is only in the range of 50%. Breast ultrasound and contrast-enhanced breast magnetic resonance imaging (MRI) have become additional standard modalities used in the diagnosis of breast cancer.

View Article and Find Full Text PDF

Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q.

Plast Reconstr Surg

August 2009

New York, N.Y.; Hamilton and Vancouver, Canada; and London, United Kingdom From the Memorial Sloan-Kettering Cancer Center, McMaster University, University of British Columbia, and University College London.

Background: Measuring patient-reported outcomes has become increasingly important in cosmetic and reconstructive breast surgery. The objective of this study was to develop a new patient-reported outcome measure to assess the unique outcomes of breast surgery patients.

Methods: Patient interviews, focus groups, expert panels, and a literature review were used to develop a conceptual framework and a list of questionnaire items.

View Article and Find Full Text PDF

A systematic review of patient-reported outcome measures after facial cosmetic surgery and/or nonsurgical facial rejuvenation.

Plast Reconstr Surg

June 2009

New York, N.Y.; Ann Arbor, Mich.; London, England; and Hamilton, Ontario, and Vancouver, British Columbia, Canada From the Memorial Sloan-Kettering Cancer Center, the University of Michigan, the London School of Hygiene and Public Health, McMaster University, and the University of British Columbia.

Background: Patient satisfaction and improved quality of life are the predominant considerations determining success in cosmetic surgery. However, few studies have examined patients' perceptions of their appearance following cosmetic facial surgery and/or nonsurgical facial rejuvenation. This study identified patient-reported outcome measures developed and validated for use in patients undergoing surgical and/or nonsurgical cosmetic procedures.

View Article and Find Full Text PDF

Measuring quality of life in cosmetic and reconstructive breast surgery: a systematic review of patient-reported outcomes instruments.

Plast Reconstr Surg

September 2007

New York, N.Y.; London, United Kingdom; Vancouver, British Columbia, Canada; and Lebanon, N.H. From the Memorial Sloan-Kettering Cancer Center, University College London, University of British Columbia, and Dartmouth-Hitchcock Medical Center.

Background: Patient-reported outcomes in cosmetic and reconstructive breast surgery are increasingly important for clinical research endeavors. Traditional surgical outcomes, centered on morbidity and mortality, remain important but are no longer sufficient on their own. Quality of life has become a crucial research topic augmenting traditional concerns focused on complications and survival.

View Article and Find Full Text PDF

Background: The purpose of this investigation was to evaluate the effect of drains on complications, including infection, seroma, and hematoma formation, in patients undergoing exchange of a temporary expander for a permanent breast implant.

Methods: A review of all tissue expander/implant breast reconstructions performed at a single center from 1997 to 2004 was undertaken. Two patient cohorts were identified: patients who underwent exchange of their expander to a permanent implant with the use of closed-suction drains and patients who underwent the exchange procedure without the use of drains.

View Article and Find Full Text PDF

Challenging the platinum combinations: Docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer.

Semin Oncol

February 2001

From the University General Hospital of Iraklion, Crete, Greece; From the Department of Clinical and Biological Sciences, University of Turin, Turin, Italy; From the Memorial Sloan Kettering Cancer Center, New York, NY U.S.A.; From the St John's Mercy Medical Center, St Louis, MO U.S.A.; From the Centre R Gauducheau, St Herblain, France; From the Thorax Klinik, Heidelberg, Germany.

The limited single-agent activity of cisplatin, its toxicity profile, and the inconvenience involved in hydrating patients has compelled researchers to investigate other treatments as possible alternative therapies in non-small cell lung cancer. More recently, interest has focused on the potential of nonplatinum combinations. Phase II studies show that the combination of docetaxel (Taxotere; Aventis, Antony, France) and gemcitabine is active in stage IIIB/IV non-small cell lung cancer not previously treated by chemotherapy.

View Article and Find Full Text PDF